Hass하스
450330 · KOSDAQ · ₩450330 · 하스
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩662
vs the current price (₩4,125)
- Enterprise value
- −₩2.3B
- Equity value
- ₩5.4B
- WACC
- 7.5%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 84% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩4,125, the model needs an operating margin of 15.3% every year (it uses 2.7%).
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩374
- −90.9%
- Base
- ₩662
- −84.0%
- Bull
- ₩1,283
- −68.9%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (2.7%).
Revenue growth
- 2.6%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (2.6% a year, annual reports), fading to 3% by year 5.
- 2.7%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (2.6% a year, annual reports), fading to 3% by year 5.
- 2.8%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (2.6% a year, annual reports), fading to 3% by year 5.
- 2.9%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (2.6% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 1 years' revenue growth (2.6% a year, annual reports), fading to 3% by year 5.
Business
- 2.7%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 2 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 14.4%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 18%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 2 annual reports (cash flow statements; equipment and intangibles).
- 35%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 2 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.08%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-29.
- 0.62
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.43, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.58%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩16B
- Net debt (borrowings and leases − cash and deposits)
- −₩7.7B
- Shares
- 8,186,843
- Share price
- ₩4,125
- Market cap
- ₩34B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|
| Revenue | ₩16B | ₩17B | ₩17B | ₩17B | ₩17B | ₩18B | ₩18B |
| Growth | — | 2.6% | 2.6% | 2.7% | 2.8% | 2.9% | 3.0% |
| EBIT | ₩1.2B | ₩903M | ₩446M | ₩458M | ₩470M | ₩484M | ₩499M |
| EBIT margin | 7.7% | 5.4% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% |
| After-tax EBIT | ₩898M | ₩655M | ₩323M | ₩332M | ₩341M | ₩351M | ₩361M |
| + Depreciation | — | — | ₩2.4B | ₩2.4B | ₩2.5B | ₩2.6B | ₩2.7B |
| − Capital spending | ₩3.6B | ₩2.2B | ₩3B | ₩3.1B | ₩3.1B | ₩3.2B | ₩3.3B |
| − Working capital | — | ₩1B | ₩146M | ₩156M | ₩166M | ₩177M | ₩188M |
| Free cash flow | — | — | −₩417M | −₩434M | −₩452M | −₩471M | −₩492M |
| Discount factor | — | — | 0.930 | 0.865 | 0.805 | 0.749 | 0.697 |
| Present value | — | — | −₩388M | −₩376M | −₩364M | −₩353M | −₩343M |
Terminal value −₩626M, worth −₩436M today: 19% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩5,075 a share)Now 0.81× | ₩4,7050.93× | ₩6,4101.26× | ₩7,8791.55× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2024, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.5% | ₩760 | ₩707 | ₩641 | ₩558 | ₩450 |
| 7.0% | ₩758 | ₩710 | ₩652 | ₩581 | ₩491 |
| 7.5% | ₩756 | ₩713 | ₩662 | ₩600 | ₩523 |
| 8.0% | ₩755 | ₩716 | ₩671 | ₩616 | ₩549 |
| 8.5% | ₩755 | ₩720 | ₩678 | ₩629 | ₩571 |
Now (TTM)
- Market cap
- ₩34B
- Enterprise value
- ₩26B
- P/E
- —
- P/B
- 0.8×
- P/S
- 2.1×
- EV/EBITDA
- —
- Dividend yield
- 1.5%
Over time (at each year end)
| 2025 | 2024 | |
|---|---|---|
| Price | ₩6,270 | ₩7,020 |
| Market cap | ₩51B | ₩57B |
| P/E | 33.2× | 32.1× |
| P/B | 1.1× | 1.3× |
| P/S | 3.1× | 3.6× |
| EV/EBITDA | — | — |
| Dividend yield | 1.0% | 1.0% |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Hass | — | 0.8× | 2.1× | — | 1.5% |
| Samsung Biologics | 32.0× | 7.6× | 14.0× | — | 0.0% |
| Celltrion | 27.9× | 2.5× | 9.0× | — | 0.0% |
| Alteogen | 80.5× | 29.0× | 61.2× | — | 0.1% |
| SK biopharmaceuticals | 14.7× | 5.8× | 6.8× | — | 0.0% |
| Yuhan | 24.0× | 2.4× | 2.5× | 31.3× | 0.8% |
| HLB | — | 15.7× | 55.6× | — | 0.0% |
| Similar companies (median) | 27.9× | 6.7× | 11.5× | 31.3× | 0.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Hass / 하스 / 450330 / KRX:450330
Source: KRX statistical information